These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
440 related articles for article (PubMed ID: 9405687)
1. A system for functional analysis of Ebola virus glycoprotein. Takada A; Robison C; Goto H; Sanchez A; Murti KG; Whitt MA; Kawaoka Y Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14764-9. PubMed ID: 9405687 [TBL] [Abstract][Full Text] [Related]
2. Efficient formation of vesicular stomatitis virus pseudotypes bearing the native forms of hepatitis C virus envelope proteins detected after sonication. Tamura K; Oue A; Tanaka A; Shimizu N; Takagi H; Kato N; Morikawa A; Hoshino H Microbes Infect; 2005 Jan; 7(1):29-40. PubMed ID: 15716060 [TBL] [Abstract][Full Text] [Related]
3. Virus entry is a major determinant of cell tropism of Edmonston and wild-type strains of measles virus as revealed by vesicular stomatitis virus pseudotypes bearing their envelope proteins. Tatsuo H; Okuma K; Tanaka K; Ono N; Minagawa H; Takade A; Matsuura Y; Yanagi Y J Virol; 2000 May; 74(9):4139-45. PubMed ID: 10756026 [TBL] [Abstract][Full Text] [Related]
4. Use of vesicular stomatitis virus pseudotypes bearing hantaan or seoul virus envelope proteins in a rapid and safe neutralization test. Ogino M; Ebihara H; Lee BH; Araki K; Lundkvist A; Kawaoka Y; Yoshimatsu K; Arikawa J Clin Diagn Lab Immunol; 2003 Jan; 10(1):154-60. PubMed ID: 12522053 [TBL] [Abstract][Full Text] [Related]
5. Analysis of the molecules involved in human T-cell leukaemia virus type 1 entry by a vesicular stomatitis virus pseudotype bearing its envelope glycoproteins. Okuma K; Matsuura Y; Tatsuo H; Inagaki Y; Nakamura M; Yamamoto N; Yanagi Y J Gen Virol; 2001 Apr; 82(Pt 4):821-830. PubMed ID: 11257187 [TBL] [Abstract][Full Text] [Related]
6. Chikungunya, Influenza, Nipah, and Semliki Forest Chimeric Viruses with Vesicular Stomatitis Virus: Actions in the Brain. van den Pol AN; Mao G; Chattopadhyay A; Rose JK; Davis JN J Virol; 2017 Mar; 91(6):. PubMed ID: 28077641 [TBL] [Abstract][Full Text] [Related]
7. Control of Human T-Cell Leukemia Virus Type 1 (HTLV-1) Infection by Eliminating Envelope Protein-Positive Cells with Recombinant Vesicular Stomatitis Viruses Encoding HTLV-1 Primary Receptor. Tezuka K; Okuma K; Kuramitsu M; Matsuoka S; Tanaka R; Tanaka Y; Hamaguchi I J Virol; 2018 Feb; 92(4):. PubMed ID: 29212930 [TBL] [Abstract][Full Text] [Related]
8. Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles. Schnell MJ; Buonocore L; Kretzschmar E; Johnson E; Rose JK Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11359-65. PubMed ID: 8876140 [TBL] [Abstract][Full Text] [Related]
9. Use of a vesicular stomatitis virus complementation system to analyze respiratory syncytial virus binding. Klenk K; Roberts SR Virus Res; 2002 Dec; 90(1-2):327-35. PubMed ID: 12457986 [TBL] [Abstract][Full Text] [Related]
10. Vesicular stomatitis virus glycoprotein containing the entire green fluorescent protein on its cytoplasmic domain is incorporated efficiently into virus particles. Dalton KP; Rose JK Virology; 2001 Jan; 279(2):414-21. PubMed ID: 11162797 [TBL] [Abstract][Full Text] [Related]
11. Identification of protective epitopes on ebola virus glycoprotein at the single amino acid level by using recombinant vesicular stomatitis viruses. Takada A; Feldmann H; Stroeher U; Bray M; Watanabe S; Ito H; McGregor M; Kawaoka Y J Virol; 2003 Jan; 77(2):1069-74. PubMed ID: 12502822 [TBL] [Abstract][Full Text] [Related]
12. Replication-competent or attenuated, nonpropagating vesicular stomatitis viruses expressing respiratory syncytial virus (RSV) antigens protect mice against RSV challenge. Kahn JS; Roberts A; Weibel C; Buonocore L; Rose JK J Virol; 2001 Nov; 75(22):11079-87. PubMed ID: 11602747 [TBL] [Abstract][Full Text] [Related]